Introduction {#s1}
============

Membrane permeability has long been understood as a critical factor of bacterial survival (Hall et al., [@B58]; Ruiz et al., [@B117]). A growing field of knowledge regarding the trafficking and insertion of bacterial membrane components has succeeded in characterizing the key factors involved in membrane biogenesis in a variety of model systems. The eventual targeting of these essential barriers by molecular inhibitors or using them as vaccine candidates has the potential for inducing either bactericidal effects outright, or increased susceptibility to more established antibiotics (Chiu et al., [@B25], [@B26]; Ghanei et al., [@B57]). Enzymes/proteins found in the cytoplasm, periplasmic space, and outside the bacterial membrane have all evolved under the confines and conditions of each of these unique microenvironments. While localization of these proteins to their ultimate destination within the cell is often essential, the controlled interaction and movement of signaling molecules/nutrients/metabolites between these regions and spaces is also critical for basic microbial metabolism. More recently, studies characterizing bacterial mutants with membrane permeability defects have begun to establish that nearly all permeability deficiencies arise from mutations in the protein machinery that make up the transport apparatus for the basic components of bacterial membranes: lipoproteins, lipopolysaccharide, and outer membrane proteins (OMPs). These fundamental transport pathways are for the most part well-conserved throughout Gram-negative bacteria (Nikaido, [@B97]; Ruiz et al., [@B118]). One notable exception to this exists in the bacterial class of ε proteobacteria. Consisting of genera spanning digestive tract colonizing symbionts/pathogens (Marshall and Warren, [@B84]) to deep-sea thermal vent chemolithotrophs (Takai et al., [@B139]), this bacterial class contains numerous extremophiles for whom membrane barrier function should arguably play an indispensible role. However, upon closer bioinformatic examination, the transport pathways for each of the three major outer membrane (OM) components in ε proteobacteria appear to have significantly diverged when compared with most other Gram-negative bacteria (Cummings et al., [@B32]).

One member of this class of ε proteobacteria with significant medical relevance is the gastric pathogen *Helicobacter pylori*. Able to survive and colonize the mucosal layer in close proximity to the human gastric epithelium (Blaser, [@B11]), *H. pylori* is capable of inhabiting an environment with an acidic pH. While adaptations to this gastric environment include motility/chemotaxis (Foynes et al., [@B54]; Ottemann and Lowenthal, [@B105]; Croxen et al., [@B31]) and the production of urease, which can substantially buffer the pH around the bacterium (Scott et al., [@B125]; Weeks et al., [@B157]), maintaining a level of barrier function from the OM remains an essential element in allowing this chronic colonizer to survive in this extreme environment. In addition, each of the previously mentioned transport pathways play key roles in permitting *H. pylori* to chronically colonize its human host.

This review highlights what is known of the three pathways involved in membrane biogenesis, specifically the transport of three major components/transport systems of the OM in the majority of Gram-negative bacteria: lipoprotein, LPS, and OMPs. The importance of each of these three membrane components in *H. pylori* will be discussed in terms of relevance to infection. Each transport pathway will be examined bioinformatically and the implications for potential targets for future small molecule inhibitors and candidates for vaccine development analyzed. Special attention will be given to the identification of the periplasmic components for these transport pathways, as it appears that many are significantly divergent from those found in other model bacteria or perhaps are even absent in *H. pylori* entirely (Figure [1](#F1){ref-type="fig"}). Given the continued prominence of this bacterium in the developing world (Frenck and Clemens, [@B56]), the current state of vaccine development for this pathogen (Czinn and Blanchard, [@B33]), and an unsettling rise in the number of reports of antibiotic resistant strains (Boyanova and Mitov, [@B18a]; De Francesco et al., [@B37]), identifying novel targets for future antimicrobials is of paramount importance.

![**Membrane biogenesis pathway conserved features in *H. pylori*.** Dark features indicate high similarity scores (≤e^4^) for *H. pylori* genes compared to *E. coli* outer membrane biogenesis pathway components, which generally consist of the IM and OM spanning portions of the pathway. Lighter shaded components indicate lower similarity scores requiring comparison of numerous bacterial homologs before attaining a significant similarity score (≤e^4^) for an *H. pylori* locus. An absence of shading indicates no homolog for that component was found through sequence similarity scores, but the existence of a potentially functional protein exists, given the presence of a conserved genetic orientation at the particular locus and/or structural similarity as determined by crystal structure analysis software (RaptorX). Dotted lines indicate a complete genetic absence of homology of a pathway component. Those proteins with low sequence similarity, low structural similarity, and apparent absence of sequence and structural similarity make up most of the components found in the periplasmic regions for each of the three OM transport pathways.](fcimb-02-00029-g0001){#F1}

Lipoproteins
============

Role in infection and pathogenesis
----------------------------------

A large number of putative lipoproteins have been found in the *H. pylori* genome (Tomb et al., [@B142]). Their abundance and potential for facilitating extensive linkages between inner and OMs has been hypothesized to explain the difficulty reported in experimentally separating inner and OM layers in most *Helicobacter* and *Campylobacter* species (O\'Toole and Clyne, [@B103]). Few lipoproteins have been well-characterized in *H. pylori*, but those that have been studied play important roles in infection and the host immune response. One such lipoprotein is the highly conserved *H. pylori* adhesin A (HpaA), which was originally characterized as a neuraminyllactose-binding hemagglutinin (Evans et al., [@B48], [@B49]), and was shown later to be a lipoprotein (O\'Toole et al., [@B104]). HpaA has since been studied in depth, due to its conserved nature in most strains and its role in bacterial adhesion. Localization of HpaA has been highly disputed in the field, with some studies pointing to flagellar sheath localization (Luke and Penn, [@B79]), others showing cytoplasmic localization (O\'Toole et al., [@B104]), and others simply showing membrane association (Bolin et al., [@B12]; Lundstrom et al., [@B80]). Due to its putative adhesin classification and putative membrane association, HpaA has been examined for use as a potential vaccine candidate (Flach et al., [@B53]). Similarly, another membrane-associated lipoprotein in *H. pylori* is Lpp20, first characterized as an 18-kilodalton OM antigen (Keenan et al., [@B68]), has been shown to be immunodominant in several studies (Keenan et al., [@B67]; Bakos et al., [@B8]). While these two lipoproteins are currently the only well-examined examples in *H. pylori* to date, the presence of several other recognized lipoproteins involved in the transport pathways of both LPS and OMPs (which will be discussed subsequently) adds additional importance to this class of membrane components.

Current model for lipoprotein membrane integration
--------------------------------------------------

The mechanism for lipoprotein trafficking has been well-characterized in *E. coli* (Matsuyama et al., [@B86], [@B87]; Yakushi et al., [@B161]). In this system, lipoproteins are transported to the inner membrane via the Sec pathway, embedded into the membrane, and are subsequently sorted according to the presence or absence of an inner membrane (IM) retention signal (Masuda et al., [@B85]). Lipoproteins lacking the signal are transported to the OM. Early lipoprotein transport studies utilized spheroplasts that were generated by EDTA-lysozyme treatment, making them devoid of periplasmic proteins (Matsuyama et al., [@B86]). While these spheroplasts continued to secrete proteins from the cytoplasm that are normally destined for the periplasm and OM, the major OM lipoprotein (Lpp) was not secreted and remained in the IM, which suggested that a periplasmic factor was required for OM lipoprotein release from the IM (Matsuyama et al., [@B86]). When periplasmic-derived materials were added externally to the spheroplasts, Lpp was released from the IM, and purification of the periplasmic components identified the periplasmic chaperone LolA (Masuda et al., [@B85]). Further research involving the generation of various proteoliposomes went on to characterize the OM component of the trafficking pathway, LolB (Matsuyama et al., [@B87]), whose role is the insertion of lipoproteins into the OM. Further analysis identified integral membrane proteins LolC and LolE, as well as a soluble, cytoplasmic ATP-binding protein (LolD) that is recruited by the membrane-associated heterodimer LolCE to form a complex that acts as an ATP-binding cassette (ABC) transporter in the IM (Yakushi et al., [@B161]; Ruiz et al., [@B118]). Lipoproteins are taken up by this complex and their lipid moiety bound to LolA, which is believed to protect their fatty-acid chains from the aqueous environment of the periplasm. LolA then transports them to an OM-associated lipoprotein, LolB, which stabilizes their internalization into the OM. Exactly how LolB inserts lipoproteins into the OM has yet to be elucidated. LolA and LolB share similarity of structure, both possessing hydrophobic cavities believed to be the binding sites for the lipid moieties of lipoproteins (Takeda et al., [@B140]). The cavities are comprised of unclosed β-barrels with α helical lid domains thought to close when not in complex with any lipoprotein (Takeda et al., [@B140]). It is worth noting that LolC and LolE are highly similar in sequence, and that unlike the Lol complex found in *E. coli*, the integral membrane portion of the complex in *N. meningitidis* appears to consists of only a single LolCE homolog (encoded by NMB1235) instead of two. This can potentially be explained in that the single *N. meningitidis* protein homolog may simply form a homodimer to supplement for the missing protein component (Bos et al., [@B14]). Given the essential nature of most of these Lol complex components in *E. coli* (Narita et al., [@B95]) and the large number of lipoproteins encoded in the *H. pylori* genome previously mentioned (Alm and Trust, [@B2]; Baltrus et al., [@B9]), their use as potential antimicrobial targets is promising.

Bioinformatics of putative *H. pylori* lipoprotein transport system
-------------------------------------------------------------------

A single, IM component of the Lol complex from *E. coli* appears to be conserved in *H. pylori* (HP0787; Table [1](#T1){ref-type="table"}), with highest similarity to LolE. As mentioned previously, LolE and LolC are highly similar in *E. coli* and it has been postulated that possessing only one of these proteins may be adequate for Lol complex formation (Bos et al., [@B14]), as in the *N. meningitidis* model. Insertion mutations in HP0787 exist (Salama et al., [@B119]), however this result indicating a potential lack of essentiality of this gene should be interpreted with caution, as the generation of deletion mutants for this gene have not been possible to date (Liechti and Goldberg, unpublished results). A few genome sequencing projects have assigned *lolD* designations to a putative *H. pylori* homolog (strain B8, HPB8_1387/HP0179) (Farnbacher et al., [@B51]), however, this characterization is based solely on the ABC transporter domain, and upon closer inspection, the N-terminus of the LolD protein (approximately 100 amino acids) is missing from this *H. pylori* gene (similar dubious gene designations have been assigned in *C. jejuni*). While no definitive LolD homolog appears to exist in *H. pylori* as such, ABC transport domains are notoriously divergent in this bacteria compared with other microbes (Tomb et al., [@B142]), and dozens of potential candidates with similar domain structure exist in the genome whose functions have not yet been identified (Tomb et al., [@B142]; Marais et al., [@B83]). In addition, LolB (the lipoprotein involved in inserting new lipoproteins into the OM in *E. coli* and *N. meningitidis*) appears to be absent in *H. pylori,* and in fact is missing in all ε proteobacteria sequenced to date. A protein with poor genetic similarity to LolA, the periplasmic chaperone component, does exist in *H. pylori* (HP0785, *E* value = 0.03) and has been shown to be non-essential (Chalker et al., [@B23]). Whether this protein acts similarly to the LolA characterized in *E. coli* has yet to be discerned, however amino acid similarity alignments between HP0785 and LolA show significant similarity for the core functional regions of the chaperone, with greatest similarity existing on one of the two sides of the open β-barrel domain (Figure [2](#F2){ref-type="fig"}). When examining the *H. pylori* amino acid sequence for the less well-conserved side of the β-barrel domain, amino acids that make up two of the β strands in this region in the *E. coli* structure are absent in the *H. pylori* sequence (Figure [2](#F2){ref-type="fig"}, shown in blue) potentially indicating a smaller, more tightly packed β sheet on that side of the open β-barrel domain.

###### 

***H. pylori* putative outer membrane biogenesis complex components**.

  ***H. pylori* locus[^\*^](#TN1){ref-type="table-fn"}**   ***E. coli* homolog**   ***E* value**                           **% id./% sim.[^\*\*^](#TN2){ref-type="table-fn"}**   **Function**
  -------------------------------------------------------- ----------------------- --------------------------------------- ----------------------------------------------------- ---------------------------------------
  **Lol COMPLEX**                                                                                                                                                                
  HP0785                                                   *lolA*                  [^\*\*\*^](#TN3){ref-type="table-fn"}   [^\*\*\*^](#TN3){ref-type="table-fn"}                 Periplasmic chaperone
  HP0787                                                   *lolC*                  5e^−24^                                 23%/48%                                               Integral membrane protein
  N/A                                                      *lolB*                  --                                      --                                                    OM associated lipoprotein
  N/A                                                      *lolD*                  --                                      --                                                    IM ABC transporter domain
  (HP0787)                                                 *lolE*                  4e^−25^                                 24%/49%                                               Integral membrane protein
  **Lpt COMPLEX**                                                                                                                                                                
  HP1568                                                   *lptA*                  [^\*\*\*^](#TN3){ref-type="table-fn"}   [^\*\*\*^](#TN3){ref-type="table-fn"}                 Periplasmic chaperone
  HP0715                                                   *lptB*                  3e^−90^                                 55%/75%                                               IM ABC transporter domain
  HP1569                                                   *lptC*                  ns.                                     ns.                                                   IM associated lipoprotein
  HP1216                                                   *lptD*                  2e^−08^                                 26%/49%                                               OM LPS transport protein
  HP1546                                                   *lptE*                  ns.                                     ns.                                                   OM associated lipoprotein
  HP0362                                                   *lptF*                  [^\*\*\*^](#TN3){ref-type="table-fn"}   [^\*\*\*^](#TN3){ref-type="table-fn"}                 Integral membrane protein
  HP1498                                                   *lptG*                  [^\*\*\*^](#TN3){ref-type="table-fn"}   [^\*\*\*^](#TN3){ref-type="table-fn"}                 Integral membrane protein
  HP1082                                                   *msbA*                  2e^−79^                                 31%/57%                                               IM LPS flippase
  **BamA COMPLEX**                                                                                                                                                               
  HP0655                                                   *bamA*                  5e^−24^                                 24%/44%                                               OM β-barrel assembly component
  N/A                                                      *bamB*                  --                                      --                                                    OM associated lipoprotein
  N/A                                                      *bamC*                  --                                      --                                                    OM associated lipoprotein
  HP1378                                                   *bamD*                  [^\*\*\*^](#TN3){ref-type="table-fn"}   [^\*\*\*^](#TN3){ref-type="table-fn"}                 OM associated lipoprotein
  N/A                                                      *bamE*                  --                                      --                                                    OM associated lipoprotein
  **Sec PATHWAY**                                                                                                                                                                
  HP0786                                                   *secA*                  0.0                                     49%/64%                                               Preprotein translocase subunit
  N/A                                                      *secB*                  --                                      --                                                    Protein export chaperone
  HP1300                                                   *secY*                  7e^−105^                                42%/67%                                               Preprotein translocase subunit
  HP1203a                                                  *secE*                  [^\*\*\*^](#TN3){ref-type="table-fn"}   [^\*\*\*^](#TN3){ref-type="table-fn"}                 Preprotein translocase subunit
  HP1255                                                   *secG*                  0.001                                   35%/61%                                               Preprotein translocase subunit
  HP1550                                                   *secD*                  2e^−86^                                 37%/57%                                               Preprotein translocase subunit
  HP1549                                                   *secF*                  2e^−51^                                 35%/62%                                               Preprotein translocase subunit
  HP1551                                                   *yajC*                  3e^−17^                                 44%/76%                                               Preprotein translocase subunit
  HP1450                                                   *yidC*                  1e^−73^                                 37%/62%                                               IM protein translocase component
  HP1152                                                   *ffh*                   1e^−102^                                40%/64%                                               Signal recognition particle (SRP)
  HP0763                                                   *fts*Y                  2e^−62^                                 50%/70%                                               SRP receptor
  **Tat PATHWAY**                                                                                                                                                                
  HP0320                                                   *tatA*                  8e^−06^                                 52%/71%                                               Sec-independent translocase
  HP1060                                                   *tatB*                  0.036                                   32%/63%                                               Sec-independent translocase
  HP1061                                                   *tatC*                  4e^−39^                                 35%/57%                                               Sec-independent translocase
  **PERIPLASMIC CHAPERONES**                                                                                                                                                     
  HP0175                                                   *surA*                  5e^−08^                                 32%/46%                                               Peptidyl-prolyl *cis*-trans isomerase
  HP1019                                                   *degP*                  9e^−83^                                 42%/62%                                               Serine protease
  N/A                                                      *skp*                   --                                      --                                                    Periplasmic chaperone
  N/A                                                      *fkpA*                  --                                      --                                                    Peptidyl-prolyl *cis*-trans isomerase

Locus defined using *H. pylori* strain 26695 designations.

\% Identity and % similarity scores were based off of the regions of similarity as determined by NCBI\'s BLAST software, and as such represent %s only of the designated regions being aligned and not the entire proteins being examined.

Indicates *E. coli* first required confirmation in other ε proteobacteria (*Campylobacer jejuni*, etc.) prior to identifying the *H. pylori* homolog.

Abbreviations: N/A, indicates no homolog or putative homolog found in any sequenced *H. pylori* strain found in the NCBI database; OM, outer membrane; IM, inner membrane; ABC, ATP-binding cassette; ns., no similarity found at the sequence level (annotation based on gene localization alone).

![**LolA periplasmic lipoprotein chaperone from *E. coli* and *H. pylori* display structural homology at N-terminal region.** Similarity protein alignments were constructed between *E. coli* and *H. pylori* LolA (HP0785) amino acid sequences and a "heat map" color scheme of protein homology based on similarity scores was generated. Crystal structures of *E. coli* LolA (PDB ID: 3KSN) were then used as a template for mapping the similarity scores. Red indicates very high confidence whereas green/blue indicate lower confidence in similarity comparisons. Views presented are an overhead of the putative, lipoprotein binding domain consisting of the open β-barrel with α helix lid **(A)**, the well-conserved, N-terminal β-sheet region **(B)**, and the less conserved, C-terminal β-sheet region **(C)** (the two β-strands missing in *H. pylori* LolA are indicated in blue). Protein sequence alignments and similarity scores were generated using T-Coffee analysis software (Poirot et al., [@B108]), the "heat map" CORE index for the alignment color gradient used algorithms described in the literature (Notredame and Abergel, [@B98]), and crystal structures were obtained from the Protein Data Bank (PDB) and viewed using ICM Brower Pro (MolSoft). The dotted red line in model represents an region in the amino acid protein sequence not present in the solved crystal structure.](fcimb-02-00029-g0002){#F2}

The genetic orientation of the Lol complex-associated genes in ε proteobacteria is, in a word, perplexing. In *E. coli*, *lolCDE* (and in *Neisseria*, *lolCD*) are found in a single operon (Figure [3A](#F3){ref-type="fig"}), with *lolB* and *lolA* each existing separately, elsewhere in the genome (Yakushi et al., [@B161]). In most ε proteobacteria however, the single conserved homolog of *lolC* appears in an operon with *secA*, the cytoplasmic-localized membrane translocase. While this proximity to an essential gene may explain problems in targeting *lolC* for deletion in *H. pylori*, an added caveat exists. The *H. pylorilolA* homolog is, coincidentally, also located proximal to *secA*, albeit transcribed in the opposite direction (Figure [3B](#F3){ref-type="fig"}), potentially hinting at some selective element as of yet undetermined in either protein or lipoprotein trafficking in ε proteobacteria. Given the apparent absence of a *lolD* homolog at this locus combined with the presence of the membrane protein translocation ATPase (SecA) in its place, overlap in the Sec export pathway and the lipoprotein transport pathway in ε proteobacteria may be a distinct possibility.

![**Genetic orientation of Lol complex-homologs.(A)** Lol complex associated loci (*lolA* and *lolB*, specifically) from *E. coli* and *N. meningitidis* appear spread throughout the genome **(B)** while complex-homologs from *H. pylori* and*C. jejuni* appear to be clustered around the cytoplasmic chaperone encoding gene, *secA*. Abbreviations: *E.c*., *Escherichia coli* (K12 substr. W3110); *N.m*., *Neisseria meningitidis* (strain Z2491); *H.p*., *Helicobacter pylori* (strain 26695); *C.j*., *Campylobacter jejuni* (strain RM1221).](fcimb-02-00029-g0003){#F3}

It has previously been shown that a lipoprotein signal peptidase gene (HP0074) is essential in *H. pylori*, indicating that lipoproteins in general are important for *H. pylori* survival (Chalker et al., [@B23]). The presence of a potentially essential *lolE* homolog in the genome would support this hypothesis. The apparent absence of a *lolB* homolog in addition to *lolA* proving to not be essential however, indicates that if this transport pathway is still functional in *H. pylori*, that it may possess redundant/alternate protein components for lipoprotein periplasmic transport and OM insertion. Taken together, despite initial observations indicating a defunct pathway, the lipoprotein transport pathway in *H. pylori* is potentially viable, and given the prominence of lipoproteins encoded in the genome, this pathway represents a potential molecular target worthy of full characterization and further pursuit.

Lipopolysaccharide
==================

Role in infection and pathogenesis
----------------------------------

In most Gram-negative bacteria, the major target for the immune system during a bacterial infection is lipopolysaccharide (LPS) (Chow et al., [@B29]; Miyake, [@B90]). LPS is a key component of a Gram-negative OM, contributing to the structural integrity of the bacteria as well as providing a barrier against the host immune system. A number of cellular receptors recognize bacterial LPS and upon binding they induce an innate immune response (Caroff et al., [@B21]). The primary activator of the host response to the lipid A portion of LPS from *E. coli* is Toll-like receptor 4 (TLR4) (Chow et al., [@B29]). In many cases, the immune response resulting from the presence of LPS (also referred to as endotoxin) is so severe, that a dysregulated immune response to infection develops, known as sepsis, which can be life threatening. Studies are currently underway to develop molecular inhibitors of LPS, specifically targeting its ability to induce monocyte activation (Bosshart and Heinzelmann, [@B16]).

In examining the two predominant model microbes in the field of OM biogenesis, it is worth noting that differences in their LPS exist at a structural basis. While *E. coli* possesses true LPS, *Neiserria* expresses lipooligosaccharides (LOS) lacking the repeating O-antigen of most enteric bacteria; this distinction is thought to account for many of the dissimilarities in the immune response to the different bacteria (Zhang et al., [@B165]). *H. pylori* does produce a defined length O-chain attached to its core region whose length is variable between strains. Similar to LPS biogenesis in other bacteria, the O-chain of *H. pylori* is constructed in the cytoplasm and flipped to the periplasm where it is transferred to the core oligosaccharide by the O-antigen ligase (WaaL). Because the host\'s immune response to LPS is so robust, many pathogenic bacteria express an LPS structure that avoids detection. *H. pylori* is a well-studied example, as it can express the Lewis Blood Group (LBG) antigens and present them on the O side chain of its LPS (Appelmelk et al., [@B7]; Monteiro, [@B91]). LBG antigens are commonly associated with host monocytes, macrophages, granulocytes, and gastric epithelial cells. They are important for low-affinity adhesion to host gastric epithelial cells as well as in phagocytosis (Kirkland et al., [@B70]; Lepper et al., [@B78]) and it has been widely speculated that *H. pylori* uses this key feature to evade the host immune system (Appelmelk et al., [@B7]; Moran et al., [@B92]). The genes responsible for the creation of these bacterial LBG antigens are present throughout the genome, and many of them undergo phase variation (Wang et al., [@B155]). The variation generated in the bacterial population, whether due to phase variation or other mechanisms, results in the production of a wide array of differing LPS profiles within a given population. This is believed to be a "fine-tuning" of the bacterium\'s defenses, further enhancing the evasion of the immune response (Wang et al., [@B155]; Khamri et al., [@B69]; Salaun et al., [@B120]; Salaun and Saunders, [@B121])

In addition, *H. pylori* modifies the lipid A portion of its LPS. When first characterized, the lipid A from *H. pylori* was found to be unique and distinguishable from that of enterobacteria in that there is an absence of a phosphoryl group at the 4′-position and fatty acyl groups at the 3- and 3′-position, as well as the presence of 2-aminoethyl phosphate at the 1-position (Suda et al., [@B137]). Further studies went on to show that *H. pylori* actually synthesizes two lipid A species, a minor one resembling that of *E. coli* (bis-phosphorylated and hexa-acylated) and a major species that contains fewer acyl chains, fewer phosphate groups, and a single 2-keto-3-deoxyoctonate (Kdo) sugar attached to the disaccharide backbone (Moran et al., [@B93]; Tran et al., [@B145]). This led to the discovery that *H. pylori* modifies its lipid A and that the result is a molecule with much lower immunobiological activity (Tran et al., [@B145]). Additional studies identified that while the lipid A from *H. pylori* is initially synthesized in this hexa-acylated form, a series of modifications after synthesis can result in a tetra-acylated molecule (Stead et al., [@B133], [@B132]).

Lipid A is the "hydrophobic anchor" of the LPS, and is the biological initiator of septic shock (Raetz and Whitfield, [@B111]). Modifications of the lipid A portion of *H. pylori* LPS results in reduced immuno-reactivity by as much as 1000 times compared to the lipid A of other bacterial species (Ogawa et al., [@B101], [@B99],[@B100]; Stead et al., [@B133]). The exact mechanism by which *H. pylori* LPS interacts with the immune system is currently in dispute. While it was initially characterized that the host receptor for *H. pylori* LPS was TLR4 (Kawahara et al., [@B66]) subsequent papers have shown that *H. pylori* interacts through TLR2 and not TLR4 (Smith et al., [@B128]). This controversial finding is apparently not limited to *H. pylori*, and the same phenomenon has been shown for other Helicobacters as well (Mandell et al., [@B82]). While another study exists, showing that chemically synthesized lipid A from *H. pylori* signaled via TLR4 (Ogawa et al., [@B99],[@B100]), highly purified *H. pylori* LPS in an alternate study showed activation only through the TLR2 complex (Yokota et al., [@B163]). TLR4 expression in gastric cell lines has also been used as evidence of *H. pylori* LPS activation (Kawahara et al., [@B66]; Su et al., [@B136]; Schmausser et al., [@B124]), however in a recent paper, it was shown that *H. pylori* LPS first signals via TLR2, which then acts through nuclear factor Y (NF-Y) to activate the transcription of TLR4 (Yokota et al., [@B164]). Whatever the mechanism, the presentation of LPS on the OM of *H. pylori* is essential for colonization and pathogenesis partially for to its role in membrane barrier function, but also for its unique ability to mask this pathogen from the host immune system.

Current model for LPS integration with the outer membrane
---------------------------------------------------------

The majority of the work on the LPS transport (LPT) pathway has been conducted in *E. coli* and *N. meningitidis*, and the pathways are summarized visually in Figure [1](#F1){ref-type="fig"}. Each model bacterial system provides differing tools that allow the system to be analyzed in a slightly different way. For example, LPS is not essential for *N. meningitidis*, allowing for comprehensive mutant studies to be conducted, while the *E. coli* system provides a high degree of technical genetic manipulation to artificially deplete components and analyze the effects. Both systems have shown that the transport pathway consists of two major membrane proteins, the flippase MsbA in the IM and the β-barrel IMP/LptD in the OM. MsbA allows for LPS in the cytoplasmic IM leaflet to be "flipped" onto the periplasmic leaflet. Once there, LPS is extracted from the IM in a process believed to be powered by an ABC transporter consisting of two integral membrane proteins (LptF and LptG) as well as an additional IM protein located solely on the cytoplasmic face of the membrane (LptB). LPS moves from the IM LptBCFG complex to the OM LptDE complex, traversing the periplasm via LptA (Ma et al., [@B81]; Tran et al., [@B146]). LptA recognizes the lipid moiety of LPS and is thought to protect the highly hydrophobic lipid element from the aqueous periplasm during transport. The energy source that powers this movement of LPS across the periplasm has yet to be elucidated.

### MsbA

MsbA was initially identified as a multi-copy suppressor of *lpxL* (*htrB*) null mutants (Karow and Georgopoulos, [@B65]), originally characterized as having growth and viability defects due to the accumulation of phospholipids (Karow et al., [@B64]). Both *htrB* null mutants and temperature sensitive *msbA* conditional mutants accumulated a precursor for LPS (*N*-acetyl \[^3^H\]-glucosamine) in the IM (Polissi and Georgopoulos, [@B109]). Upon subsequent analysis, *msbA* showed high homology to various ABC transporters; one study using a temperature-sensitive *msbA* allelle constructed in a polymyxin-resistant background strain of *E. coli* showed that LPS recovered from the inner membrane did not contain modifications to the lipid A required for polymyxin resistance (Doerrler et al., [@B42]). These modifications (the covalent modification of lipid A with cationic substituents 4-amino-4-deoxy-L-arabinose and phosphoethanolamine) are believed to occur at the periplasmic leaflet of the IM, and their absence strongly indicated that the LPS in these mutants was, therefore, localized in the cytoplasmic-facing, lipid leaflet (Zhou et al., [@B166]; Doerrler, [@B41]).

Attempted mutant studies determined that *msbA* is essential for in *E. coli* (Zhou et al., [@B166]), and this was independently confirmed in *Pseudomonas aeruginosa* (Ghanei et al., [@B57]). Similar studies were conducted in *N. meningitidis*, with somewhat differing results: total LPS levels for the mutant *msbA* strain were shown to be lower in the parental strain, indicating the potential presence of a feedback inhibition pathway not seen in *E. coli* (Tefsen et al., [@B141]). It has been speculated that because the LPS appears to localize on the cytoplasmic side of the IM in *E. coli*, that MsbA plays a role in the flipping of the lipid A-core oligosaccharide onto the periplasmic side of the membrane. This flippase activity has since been confirmed in a reconstituted system (Eckford and Sharom, [@B47]). It is believed that MsbA forms a homo-dimer with a chamber oriented toward the cytoplasm capable of accommodating lipid molecules, a finding supported by crystal structure analysis (Ghanei et al., [@B57]; Ward et al., [@B156]; Eckford and Sharom, [@B46]).

### LptD

The identification of the OM protein LptD (Imp/OstA) was revealed through screening *E. coli* mutant libraries for strains with alterations in their membrane permeability (Sampson et al., [@B123]; Aono et al., [@B6]). *lptD* mutants resulted in an increased permeability of OMs to maltodextrins, dyes, as well as antibiotics (Sampson et al., [@B123]). In addition, it has been established that *lptD* is regulated by sigma factor E, a stress response regulator that reacts to disruptions of LPS structure and found to up-regulate various proteins involved in membrane biogenesis, such as periplasmic and cytoplasmic chaperones (Dartigalongue et al., [@B34]). Overexpression of LptD was only possible when LptE was also overexpressed simultaneously, and the two proteins were found to form a stable, heterodimeric complex (Chng et al., [@B27]). In *N. meningitidis*, inactivating *lptD* gave results similar to those found in the *E. colimsbA* conditional mutants: significantly reduced total cellular LPS, further confirming the linkage between LPS synthesis and transport in this model system (Braun and Silhavy, [@B19]; Bos et al., [@B13]). By using a PagL induction system (PagL acts by removing an acyl chain on the LPS after it is incorporated into the OM) researchers were able to show that the LPS isolated from *N. meningitidis* strains with an inactivated *lptD* showed no signs of this modification, indicating that the LPS was not transported to the outer leaflet of the OM (Bos et al., [@B13]). Studies in *E. coli* identified a complex partner of LptD, a lipoprotein originally named RlpB and now denoted as LptE. Conditional mutants for LptE were similar to LptD mutants in that they resulted in an increase in total cellular LPS (Wu et al., [@B160]).

### LptA and LptB

Screening for essential genes in *E. coli* lead to the classification of other proteins involved in envelope biogenesis. The proteins LptA and LptB were identified, and when these proteins were down regulated, phenotypes similar to *lptD* and *msbA* mutants were observed. In addition, the genes encoding these two proteins were found together in an operon (Sperandeo et al., [@B129]). In contrast with *E. coli*, in the *N. meningitidis* model, these genes are not essential, and when deletion mutants were generated, they were found to have severely reduced LPS production, similar to *lptD* and *msbA* mutants. Upon sequence and structural analysis, LptA was found to have no membrane spanning domains while also sharing a conserved N-terminal domain with Imp, indicating a common but as yet un-described function. The operon partner (*lptB*) encodes a protein that possesses the general features of a typical ABC transporter but also lacks any membrane spanning regions (Sperandeo et al., [@B129]). LptB exists as a 27-kDa protein that is found in a 140-kDa complex (Stenberg et al., [@B134]) and biochemical evidence of this LptB-containing complex has also been reported (Narita and Tokuda, [@B96]). LptB works in conjunction with LptC (previously YrbK) in the complex with LptBFG, an ABC transporter involved in the transport of LPS. LptA is believed to act as a periplasmic chaperone, delivering LPS to the OM, where LptD acts to orient it (Sperandeo et al., [@B129]; Tran et al., [@B146]).

While the components of the transport system are characterized, the exact mechanism of transport through the periplasm is still in dispute. The two competing hypotheses differ not in what proteins are involved but rather their orientation to each other during transport. The chaperone hypothesis proposes that LptA acts similarly to LolA of the lipoprotein transport pathway or Skp, DegP, and SurA of the membrane protein transport pathway (Sperandeo et al., [@B129]). The competing hypothesis is the "periplasmic bridge" model (Bayer, [@B10]; Tefsen et al., [@B141]; Sperandeo et al., [@B129]) in which all components together make up a protein bridge that effectively connect both membranes and simply pass LPS between themselves until it arrives in the OM. Characterized crystal structures of long, fiber-like structures formed by multiple LptA molecules arranged in head-to-tail fashion while in the presence of LPS (Suits et al., [@B138]; Merten et al., [@B88]) seem to support the periplasmic bridge model.

A number of other studies seem to favor this "periplasmic bridge" or "trans-envelope" model. Lpt proteins have been shown to colocalize and can be found in both OM and IM preparations (Chng et al., [@B27]). LptA was first believed to be soluble and localized only in the periplasm (Sperandeo et al., [@B130]) however, subsequent experimentation has shown that LptA preferentially interacts with membranes and that polyhistidine tags that were used to purify the protein are potentially culprits in effecting the localization that was observed in previous studies (Chng et al., [@B27]). Subsequent experimentation has also shown that defects in components of the Lpt pathway in either the OM or IM result in LptA degradation, potentially indicating that LptA levels can act as a marker for proper formation of the transmembrane bridge (Sperandeo et al., [@B131]). The evidence of the existence of these bridges appears definitive, however, whether these bridges are transient or always present remains to be elucidated.

### LptC and LptE

The roles of the stabilizing proteins LptC and LptE have only more recently been clarified. Studies have found that while LptC interacts directly with LptA (Sperandeo et al., [@B131]; Bowyer et al., [@B17]), LptE does not (Bowyer et al., [@B17]). The structure of LptC is highly similar to that of LptA, and it has been shown that like LptA, LptC binds LPS *in vitro* (Tran et al., [@B144]). Additionally, LptA can displace LPS from LptC *in vitro* but LptC cannot displace LPS from LptA, indicating a unidirectional export pathway (Tran et al., [@B144]). LptE has been shown in *E. coli* to interact directly with LPS (Chng et al., [@B27]) and it is theorized to act as a substrate recognition site at the OM. However, when LptE was deleted from *N. meningitidis*, LPS transport to the cell surface was not noticeably affected and only levels of LptD were altered (Bos and Tommassen, [@B15]) indicating a potential role in trafficking of LptD to the membrane. One study has shown that several residues of LptE interact directly with LptD *in vivo*, specifically in a predicted extracellular loop structure, and a "plug-and-barrel" architecture in which LptE resides within the LptD β-barrel has been postulated (Freinkman et al., [@B55]). The interaction between LptD and LptE has also been shown to occur while LptD is being assembled into the membrane by the Bam complex (Chimalakonda et al., [@B24]).

It has been proposed that LPS itself may play a role in membrane biogenesis, specifically in OMP transport (Bulieris et al., [@B20]; Qu et al., [@B110]). This appears to be species-specific however, as in *N. meningitidis*, OMP biogenesis is independent of LPS. Predicted binding domains for LPS appear to exist on the periplasmic chaperone Skp in both *E. coli* (Walton and Sousa, [@B154]) and *N. meningitidis*, indicating the potential for at least some overlap between the LPS and OMP transport pathways, however Skp-LPS interactions have to date only been detected *in vitro* (de Cock et al., [@B36]). A less direct and more plausible effect of LPS on OMP biogenesis has been described, in which LPS acts merely to stabilize membrane proteins that have already been transported to the membrane via mediating rearrangements of the proteins\' surface-exposed loops (de Cock and Tommassen, [@B35]). Porin trimers have been shown to be stabilized in this fashion (de Cock and Tommassen, [@B35]).

Bioinformatics of putative *H. pylori* LPS transport system
-----------------------------------------------------------

From a genetic standpoint, the LPS transport pathway in *H. pylori* appears to be conserved in regard to the integral membrane proteins MsbA, LptB, and LptD (Table [1](#T1){ref-type="table"}). The encoding genes (HP1082, HP0715, and HP1215/1216, respectively) are present in all sequenced *H. pylori* isolates available (strains 26695, J99, HPAG1) as well as *Helicobacter acinonychis* and *Campylobacter jejuni* and are highly conserved when compared with their *E. coli* homologs. Transposon mutagenesis studies have generated mutations in all three genes (Salama et al., [@B119]), however, whether the proteins are still functional in these mutants is not known.

Both *msbA* and *lptD* were found to be significantly up-regulated when *H. pylori* strain NTUH-C1 was treated with glutaraldehyde (Chiu et al., [@B26]) and Δ*lptD* and Δ*msbA* mutants have been characterized in the same *H. pylori* strain (Chiu et al., [@B25], [@B26]). These researchers determined that their mutants, derived from the clinical isolate NTUH-C1, were more susceptible to both n-hexane as well as several antibiotics (novobiocin, erythromycin, tetracycline, and penicillin) when compared to the parental strain, suggesting that MsbA and LptD play an important role in maintaining membrane integrity in *H. pylori*. Silver staining of proteinase-K digested whole cell lysates indicate lower amounts of total LPS present in Δ*lptD*, Δ*msbA*, and Δ*lptD*Δ*msbA* mutants. Immunoblots using antibodies for Lewis antigens A and B on *H. pylori* LPS preparations were used to show the amounts of O-antigen in the preparations, and both antibodies showed significantly reduced amounts of O-antigen in all three mutants (Chiu et al., [@B26]). While these studies raise the potential that *H. pylori* can exist without LPS, as of yet, no examination of the lipid A of these mutants has been conducted. LptA and LptD from *E. coli* have been shown to interact with the lipid A moiety of LPS, indicating that it is lipid A that is actually the key component that is being transported by the Lpt transport pathway. There are examples in the literature of alterations in *H. pylori* lipid A resulting in a "truncation of the core oligosaccharide and loss of the attachment of the O sidechain containing Lewis X and Y" (Moran et al., [@B94]) and the expression of Lewis antigens in a cholesterol-dependent manner (Hildebrandt and McGee, [@B61]), however, no studies to date have shown that *H. pylori* can exist without lipid A in its OM, or have shown an alternate pathway for lipid A integration into the membrane. Strain specificity potentially plays a role with regard to the generation of membrane biogenesis mutants in *H. pylori*, as at present, generating directed insertion or deletion or mutants in *lptD*, *msbA*, or any of the other components of the Lpt complex in strains 26695, G27, 1061, or SS1 have proven unsuccessful (Liechti and Goldberg, unpublished results).

In searching for possible homologs for all the components of the LPS trafficking from *E. coli* in *H. pylori*, an interesting phenomenon found in all of *H. pylori* membrane trafficking pathways again presents itself. While the membrane spanning pathway components appear quite similar to their *E. coli* counterparts (Table [1](#T1){ref-type="table"}), the components localizing to the periplasmic region of the pathway appear barely conserved and potentially non-existent in any recognizable form. Putative *H. pylori* homologs to LptF and LptG (HP0362 and HP1498, respectively) were only found after identifying homologs with either *E. coli* or *N. meningitidis* proteins in *Helicobacter hepaticus* (HH0602 and HH1496, respectively). The purported periplasmic LPS chaperone, LptA, found in both *E. coli* and *N. meningitidis* is present in *H. pylori*, albeit at a very low similarity, whereas the membrane-associated ABC transporter component LptB is highly conserved. Analysis of the putative *H. pylori* LptA shows high structural similarity at the central region of the protein, and interestingly the majority of divergence from the *E. coli* homolog exists at both the N- and C-termini (Figure [4](#F4){ref-type="fig"}). These regions of lower similarity comprise the putative points of interaction between LptA molecules when they form polymers, resulting in a twisted, β-jellyroll structure, in the presence of LPS (Suits et al., [@B138]). No obvious homologs exist for either LptC and LptE in *H. pylori* or any ε proteobacteria at the level of amino acid identity/similarity, however one report from the literature indicates that *lptE* is always present in a common locus in most bacterial genomes, and when it does not appear to exist on the level of genetic similarity, a putative lipoprotein can be found in its same genetic locale (Bos and Tommassen, [@B15]). In the case of *H. pylori*, a putative lipoprotein that shares common domain characteristics of LptE orthologs exists at this locus, directly downstream of *leuS* (Figure [5](#F5){ref-type="fig"}) and this appears to be the case for all other ε proteobacteria as well (Bos and Tommassen, [@B15]). When protein structural analysis software \[RaptorX, (Peng and Xu, [@B107])\] is used to compare the putative *H. pylori* protein at the structural level to all solved crystal structures in the Protein Data Bank, the two most structurally similar proteins are characterized as "rare lipoprotein B" (early nomenclature for LptE) from *Nitrosomonas europaea* and *Shewanella oneidensis* (PBD designations 2JXP and 2R76), respectively. Similarly, a conserved protein in ε proteobacteria appears to exist in the same genetic locus as *lptC* (directly upstream of the *lptA* homolog) (Figure [6](#F6){ref-type="fig"}). Similarly, the *H. pylori* homolog to *lptB* (HP0715) is found directly upstream of *rpoN*, similar to its genetic localization in *E. coli* and *N. meningitidis*. Amino acid alignments show well-conserved residues in the N-terminus of the putative *H. pylori* LptC and poorer similarity past ∼ residue 110. The LptC periplasmic domain has been described as a "twisted boat" structure comprised of two β-sheets in opposition to each other (Tran et al., [@B144]) and the *H. pylori* putative protein possesses amino acid similarity through the first five β-strands (Figure [7](#F7){ref-type="fig"}). Unlike LptE, LptC is believed to be the crucial link between LptA and the ABC transporter (LptBFG) and as all localization and protein interaction data to date supports this hypothesis, the presence of a potential LptC-like protein in ε proteobacteria is encouraging.

![**LptA periplasmic LPS chaperone displays greatest structural homology at the central region.** Similarity protein alignments were generated between LptA amino acid sequences from *E. coli* and *H. pylori* (HP1568) and a color scheme based on similarity scores was generated, described previously in Figure [2](#F2){ref-type="fig"}. Crystal structures of LptA from *E. coli* \[PDB ID: 2R19, (Suits et al., [@B138])\] were then used as a template for mapping the similarity scores. Monomeric **(A--C)**, as well as the dimeric **(D--F)** "head-to-tail" conformation (in which the N-terminal β-strand from each molecule interacts with the C-terminal β-strand of the adjacent LptA molecule) of protein structures are shown. Greatest similarity is found in the central portions of the protein (shown in red) whereas areas believed to be involved in monomer stacking to form filamentous structures, believed to potentially span the periplasm, give significantly lower similarity scores (shown in yellow and green). The dotted yellow and red lines in the model represents regions in the amino acid protein sequence not present in the solved crystal structure.](fcimb-02-00029-g0004){#F4}

![**Genes encoding putative lipoproteins of unknown function are found adjacent to *leuS* (leucyl-tRNA synthetase) in ε proteobacteria.** While having limited sequence similarity to *lptE*, the conserved orientation of the lipoprotein encoding genes downstream of *leuS*, in addition a high similarity score at the putative protein structural level to LptE from *Nitrosomonas europaea* and *Shewanella oneidensis* \[Protein DataBase \#s 2JXP and 2R76, respectively: analysis conducted utilizing the 3D modeling software RaptorX: (Di Tommaso et al., [@B39])\] indicates the potential of a functionally equivalent protein in all ε proteobacteria species observed.](fcimb-02-00029-g0005){#F5}

![**Apparent genetic reorientation of Lpt operon in ε proteobacteria.** While the orientation of *lptA*, *lptB*, and *lptC* in most Gram-negative bacteria is that of a single putative operon, the locus in ε proteobacteria appears to have dissociated while still maintaining many of the genes proximal to the Lpt components, namely *rpoN* and *kdsC*.](fcimb-02-00029-g0006){#F6}

![**LptC displays greatest structural homology at the N-terminal region.** Ribbon structure of LptC protein from *E. coli* \[PDB ID: 3MY2, (Tran et al., [@B144])\] with areas of similarity to the *H. pylori* homolog (HP1569) displayed in color code described previously in Figure [2](#F2){ref-type="fig"}. Views presented are overhead **(A)** and side **(B--C)** profiles.](fcimb-02-00029-g0007){#F7}

Outer membrane proteins
=======================

Role in infection and pathogenesis
----------------------------------

*H. pylori* contains an OMP family consisting of approximately 33 genes. This family is divided into two subfamilies comprising of the *H. pylori* outer membrane protein (Hop) and the Hop-related (Hor) families (Alm and Trust, [@B2]). The vast majority of *H. pylori* OMPs belong to the Hop sub-family, including almost all known adhesion proteins that allow for the binding of *H. pylori* to numerous substrates from fucosylated histo-blood group antigens (Ilver et al., [@B63]) to host laminin (Senkovich et al., [@B126]). The protein family also contains a substantial number of porins (Exner et al., [@B50]; Doig et al., [@B44]; Peck et al., [@B106]) thought to play roles in nutrient uptake, though to date, no study has closely examined their function with regard to specificity of substrates. It is also worth noting that the flagella apparatus (Eaton et al., [@B45]) and chemotactic machinery (Foynes et al., [@B54]; Croxen et al., [@B31]) of *H. pylori* are both essential for colonization and both possess OM and IM protein components, as do the transport pathways for LPS and lipoproteins, not to mention the Cag and Com type IV secretion systems, required for injecting the CagA protein into host cells (Censini et al., [@B22]) and taking up DNA for homologous recombination (Stingl et al., [@B135]), respectively. It is quite extraordinary how almost everything required for the survival and pathogenesis of *H. pylori* (DNA and nutrient uptake, adherence, motility, chemotaxis, immune stimulation/evasion, VacA secretion, iron acquisition, etc.) requires β-barrel proteins in the OM; these proteins may all depend on a single mechanism by which they are inserted into the OM.

Current model for membrane protein integration
----------------------------------------------

In attempting to use *E. coli* as a model to discern proteins involved in OM biogenesis, researchers needed to designate set criteria to judge whether a given protein was likely involved in the transport pathway. They reasoned that defects in membrane transport would result in a loss of barrier function and membrane permeability would significantly increase as a result (Braun and Silhavy, [@B19]; Ruiz et al., [@B118]). Therefore, alterations in membrane permeability became a key element to examine when considering potential candidate proteins for OMP transport. It was also shown early on that mis-folding of OMPs resulted in an envelope stress response, in which various chaperones involved in the protein transport pathway were up-regulated (Cosma et al., [@B30]; Raivio and Silhavy, [@B112]). Genes involved in the OM transport pathways were also assumed to exist in operons with other transport pathway genes in addition to being essential in *E. coli* and well-conserved in other bacteria. The ultimate test for proteins playing roles in OM biogenesis was depletion experimentation using either temperature-sensitive mutants or inducer-dependent expression systems. In both cases, levels of OMPs could be examined and locations within the cell detected and compared with wild-type bacteria. It was also shown that, in many cases, problems in OMP transport resulted in a down-regulation of membrane proteins, preventing the accumulation of mis-folded proteins at various stages of the transport process (Werner and Misra, [@B158]; Ruiz et al., [@B118]; Bos et al., [@B14]).

This basic understanding of membrane biogenesis became much less universal once similar studies were conducted in the bacterium *N. meningitidis*. In stark contrast to *E. coli*, *N. meningitidis* proved a more complicated model for recognizing new transport pathway components for a number of reasons. For example, *N. meningitidis* appears to completely lack the majority of proteins involved and essential for a periplasmic stress response (Bos et al., [@B14]), as characterized by the *E. coli* system. In addition, numerous genes identified as essential components of the OM biogenesis apparatus in *E. coli* are not essential in *N. meningitidis* (Bos et al., [@B14]). This does allow for the creation of mutants in this model system however, enabling a more straightforward, reductionist approach.

SEC-dependent and -independent transport
----------------------------------------

The *sec* pathway is a well-established system for trafficking proteins from the cytoplasm through the IM to the periplasm. In this transport pathway, chaperones SecA and SecB sequester proteins bound for the IM transport pathway by recognizing leader sequences on the designated protein (Kumamoto and Francetic, [@B74]; Valent et al., [@B147]). These chaperones then bring the newly formed protein to the membrane-localized portion of the Sec complex (SecDEFGY) (Van den Berg et al., [@B148]), which acts to move the protein through the IM. SecA then acts as the ATPase motor for this protein transport channel, providing energy for the mechanical "pushing" of the preproteins through the SecYEG complex (Tomkiewicz et al., [@B143]) and in so doing changes localization from cytoplasmic to peripheral IM and finally to integral IM. The leader sequence on the preprotein is removed by a leader peptidase, and the protein is then generally recognized by various periplasmic chaperones. In addition to the SecB-dependent transport of preproteins to the SecYEG complex, an alternate means of cytoplasmic transport exists (Koch et al., [@B71]) in the signal recognition particle (SRP) that recognizes either signal recognition peptides or the first transmembrane segment of proteins targeted for the IM. Once bound to the preprotein, the SRP complex migrates to the membrane, where a SRP receptor catalyzes the release of the preprotein and its insertion into the SecYEG complex. While initially it was thought that the majority of OMPs were SecB-dependent (Kumamoto and Beckwith, [@B75]), it has also been shown that OMPs misdirected to the SRP-dependent pathway can be secreted across the IM and are correctly assembled in the OM (Lee and Bernstein, [@B76]; Bowers et al., [@B18]).

Another IM transport pathway for proteins has also been characterized. Known as the Twin-Arginine Translocation (Tat) complex, this system involves three IM proteins (TatA, TatB, and TatC) that allow for protein transport independent of the Sec pathway (Lee et al., [@B77]). The general model for this complex is that TatA, with its multiple membrane spanning domains, forms a pore complex, while TatB and TatC stabilize the complex and allow for interactions with incoming cytoplasmic proteins. The three genes encoding these proteins are found in a single operon in *E. coli* and mutants have shown defects in IM trafficking for certain proteins (Lee et al., [@B77]). It has been postulated that the Tat pathway generally is utilized for proteins that undergo the majority of their conformational changes in the cytoplasm, as the transport pathway is relatively fast as compared with the Sec pathway. Studies have shown that mutations of genes encoding proteins involved in this pathway in various bacteria can result in a loss of infectivity resulting from the mislocalization of virulence determinants, which are normally moved through the periplasm by this mechanism (Voulhoux et al., [@B151]; Lee et al., [@B77]).

BAM (β-barrel assembly machinery) complex
-----------------------------------------

Recent *E. coli* studies have led to the discovery of an OM component of the OMP trafficking pathway, the Bam (YaeT) complex (Ruiz et al., [@B118]). Researchers, in an attempt to identify proteins potentially involved in membrane biogenesis, created an *E. coli* strain with a defective *lptD* allele. Barrier function of the OM in wild-type *E. coli* generally results in resistance to a number of antibiotics and various toxic compounds. However, *E. coli* strains containing mutations in key OM biogenesis genes, such as *lptD*, display a "leaky phenotype" in that their membranes are more permeable and as a consequence these mutants show increased susceptibility to toxins and antibiotics. By using the *lptD* mutant as a starter strain, and then selecting for spontaneous suppressor mutations that result in a return to wild-type levels of antibiotic resistance, researchers were able to characterize other proteins involved in the transport pathway (Ruiz et al., [@B117]). Among the mutations identified was the *yfgL* (*bamB*) gene, encoding an OM-associated lipoprotein. Co-immunoprecipitation studies revealed that BamB existed in a complex in the OM with three other lipoproteins; YfiO (BamD), NlpB (BamC), and SmpA (BamE), as well as the β-barrel protein BamA (Wu et al., [@B159]).

The homolog of BamA in *N. meningitidis* (Omp85) had previously been linked to OM biogenesis, and it was initially uncertain whether it also had an additional role in transport of LPS (Voulhoux et al., [@B152]; Voulhoux and Tommassen, [@B153]). Subsequent experimentation was able to show that LPS transport is affected when the overall levels of BamA are reduced. This effect was later found to be indirect, as the alterations in LPS transport were the result of the OMP of the LPS transport pathway (LptD) not being inserted correctly into the membrane (Bos et al., [@B13]). In both bacterial systems, *bamA* is an essential gene and is involved in the assembly of β-barrel proteins. In examining its genetic orientation, it was discovered that *bamA* is flanked by two other genes involved in membrane trafficking: the periplasmic chaperone *skp* as well as *yaeL*, a protease involved in the envelope stress response described earlier (Bos et al., [@B14]). Lipoprotein BamD was also shown to be essential for viability in *E. coli* and *N. meningitidis*, while mutations in the other three lipoproteins result in only mild alterations in membrane permeability (Onufryk et al., [@B102]; Wu et al., [@B159]). However, upon comparison of the pathway mechanics of both microbes, significant differences emerged. Depletion studies for BamA in *E. coli* showed no alteration in LPS trafficking, indicating no role for BamA involving LPS in *E. coli* (Doerrler and Raetz, [@B43]). It was also shown that depletion for BamA in *N. meningitidis* led to the accumulation of unfolded OMPs in the IM (Voulhoux et al., [@B152]) while in *E. coli*, depletion resulted in significantly reduced amounts of all OMPs (Wu et al., [@B159]). It is believed this is due to the absence of the envelope stress response in *N. meningitidis*, thereby preventing the down-regulation of OMP synthesis (Bos et al., [@B14]). Subsequent studies have also shown that BamA also acts as the receptor for contact-dependent growth inhibition (CDI) in *E. coli*, and that antibodies specific for extracellular epitopes on BamA block inhibitor cell binding (Aoki et al., [@B4]). The potential for utilization of CDI to target bacterial growth is currently being examined (Aoki et al., [@B5]).

Periplasmic chaperones
----------------------

The four major periplasmic proteins involved in OMP transport in *E. coli* are SurA (Rouviere and Gross, [@B115]), DegP (Misra et al., [@B89]; Krojer et al., [@B72]), FkpA (Dartigalongue et al., [@B34]), and Skp (Harms et al., [@B60]; Bulieris et al., [@B20]; Walton and Sousa, [@B154]). Unlike various other members of the OM biogenesis pathway, Skp as well as other periplasmic chaperones, have been shown to be non-singularly essential, and mutants in *E. coli* show only modest defects in membrane biogenesis (Rizzitello et al., [@B114]). This has led to the belief that potentially multiple mechanisms exist for periplasmic trafficking, a view supported by greater OM defects seen in sequential knockout studies for other established periplasmic chaperones (Rizzitello et al., [@B114]), indicating the presence of parallel pathways. To date, SurA is recognized as the main periplasmic chaperone, with Skp/DegP acting as a back-up pathway (Sklar et al., [@B127]). Evidence does however exist in the literature that some proteins appear to be preferentially transported by SurA (Vertommen et al., [@B149]). LptD is currently believed to be transported through the periplasm by the SurA chaperone with cooperation from periplasmic disulfide isomerase (DsbC) and thiol oxidase (DsbA) (Denoncin et al., [@B38]). Further analysis revealed that LptD contains two disulfide bonds that are essential for function that act to stabilize the LptD protein by correctly positioning the N- and C-terminal domains of the protein in the periplasm (Ruiz et al., [@B116]) and that oxidation is carried out by DsbA. However, this apparent preference for periplasmic chaperones is potentially species-specific, as Δ*surA* mutants generated in *N. meningitidis* did not appear to affect membrane biogenesis, while a Δ*skp* mutant resulted in significantly lower levels of porins PorA and PorB (Volokhina et al., [@B150]).

Bioinformatics of putative *H. pylori* OMP transport system
-----------------------------------------------------------

A large number of the membrane-associated proteins found on the surface of *H. pylori* consist of β-barrels, indicating their transport through the membranes from the cytoplasm may be through the Sec and BamA complex (Table [1](#T1){ref-type="table"}). The importance of the Sec pathway in *H. pylori* was made readily apparent via bioinformatic analysis of the *H. pylori* strain 26695, where it was found that 517 of the 1,590 open reading frames possessed putative signal sequences (Alm et al., [@B1]). The Sec pathway for IM transport has already been well-characterized in *H. pylori* and transposon mutagenesis studies have shown that many of the genes encoding components of the Sec-pathway are capable of being mutated (albeit definite conclusions based on these results should be tempered with the knowledge that often insertions in a gene do not always lead to a complete inactivation of that gene), with the exception of *secY* (Salama et al., [@B119]). *H. pylori* does seem to lack the cytoplasmic chaperone SecB, but this is apparently common and has been characterized in other bacterial species (Yamane et al., [@B162]), indicating SecB acts to supplement the effectiveness of SecA. This may also hint at a more pronounced role for the SRP-dependent pathway in OMP trafficking to the Sec complex in *H. pylori*, however, to date no studies have tested this potential hypothesis.*E. colisecD* and *secG* temperature-sensitive mutants when grown at the non-permissive temperature result in the accumulation of OMPs in the cytoplasm (Fitchen et al., [@B52]). However, when complementation studies were preformed using plasmids expressing the *H. pylori* homologues in these mutants, cytoplasmic OMP levels returned to their wild-type levels, indicating a conservation in function for these genes in *H. pylori* (Fitchen et al., [@B52]).

Similarly, the Sec-independent IM transport system, the Tat complex, appears to be well-conserved in *H. pylori*. *tatA* (HP0320), *tatB* (HP1060), and *tatC* (HP1061) are all present (Table [1](#T1){ref-type="table"}), with the only difference being the apparent removal of *tatA* from the original operon and insertion elsewhere in the genome, whereas in *E. coli* the three genes comprise a single operon (Lee et al., [@B77]). No characterized mutants for *tatB* or *tatC* have been described while a single transposon insertion mutant exists for *tatA* (Salama et al., [@B119]) and the low coverage of transposon mutants in these genes suggests that all three maintain an essential function in *H. pylori*. This would seem to differ with previous studies in *E. coli* where the Tat system has been shown to be dispensable under laboratory conditions, however, there are examples of bacteria that rely heavily on the Tat system for almost all protein secretion (Dilks et al., [@B40]).

The periplasmic chaperones DegP and SurA appear to be conserved in *H. pylori*, while the chaperone Skp does not appear to be well-conserved. *N. meningitidis* is similar to *H. pylori* in this respect, as it posseses only *surA* and *skp* homologs and is missing a functional *degP* homolog (Volokhina et al., [@B150]). The synthetic lethal phenotypes characterized in *E. coli* double mutants (*surA*/*skp* and *surA*/*degP*) indicate that SurA and Skp/DegP exist in parallel periplasmic chaperone pathways, and the absence of a Skp homolog in *H. pylori* is possible due to the presence of SurA. No mutants in *degP* or *surA* have been characterized to date in *H. pylori* however, and insertional mutants in these genes were not generated in the construction of a transposon library in *H. pylori* of ∼10,000 clones (Salama et al., [@B119]), indicating that they may be essential.

The integral OMP component of the OMP trafficking pathway, BamA, is well-conserved in *H. pylori* (Table [1](#T1){ref-type="table"}) and all ε proteobacteria. What is striking is that in *E. coli* and *N. meningitidis,* this protein is part of a complex along with at least four other conserved lipoproteins (BamB, BamC, BamD, and BamE) while in *H. pylori* only BamD (ComL) appears to be present. It is worth noting that BamA and BamD appear to form the core of the OMP export machinery, as they are the only two essential components in both *E. coli* and *N. meningitidis*. In *E. coli* BamE has been recently shown to modulate the conformation of BamA, likely through its interactions with BamD, and when Δ *bamE* mutant cells are treated with proteinase K, BamA is degraded beyond recognition (Rigel et al., [@B113]). No studies on the Bam complex have been reported in *H. pylori* to date.

Perspectives
============

There is currently a relatively large amount of circumstantial genetic evidence suggesting that the OM biogenesis pathways established in *E. coli* and *N. meningitidis* are present in some form or derivation in *H. pylori* and in fact all ε proteobacteria. The OM- and IM-protein components of all of these pathways appear to be conserved (Table [1](#T1){ref-type="table"}), but what is striking is that, in these initial genetic and bioinformatic observations, nearly all of the periplasmic components from each of these characterized pathways from *E. coli* and *N. meningitidis* are missing or severely altered in all ε proteobacteria (Figure [1](#F1){ref-type="fig"}). An examination of the divergent residues of putative *H. pylori* homlogs for LolA, LptA, LptC, and LptE all indicate that in general, the N-terminal domains are conserved, while the more C-terminal domains are not. Divergence at the N- and C-terminal domains of the *H. pylori* LptA homolog are particularly interesting, as these residues are potentially important for the formation of the long, end-to-end, filamentous structures formed in the presence of LPS. Regions of interaction between filament monomers are generally well-conserved between bacterial species, given the importance of monomer-monomer interaction (Samatey et al., [@B122]), however, instances of variability at these binding domains are present in the *H. pylori* literature (Andersen-Nissen et al., [@B3]). Given that all of the membrane-associated components from each transport system are present and given that in every case, the periplasmic-associated components are highly divergent or potentially missing, there appears to be some strong, and as of yet uncharacterized selection affecting the periplasmic components of all three of the discussed transport pathways in *H. pylori* and other ε proteobacteria.

Little is known about the conditions inside the periplasm of *H. pylori* and the field of periplasmic transport has only just begun to expand. Recent studies have examined the transport of urea via UreI for use in buffering the periplasm in *H. pylori*, maintaining a pH of ∼6.1, compared to a pH as low as ∼2 outside of the OM and pH greater than 7 in the cytoplasm (Scott et al., [@B125]; Weeks et al., [@B157]; Krulwich et al., [@B73]). In this respect "the key to gastric colonization by *H. pylori* is periplasmic pH homeostasis" (Krulwich et al., [@B73]). The possibility exists that using the periplasmic space as a pH buffer may be driving this apparent selection affecting the composition of periplasmic-associated lipoproteins as well as potential periplasmic chaperones in all three, membrane biogenesis transport systems. Divergence in sequence perhaps reflects amino acid domains important for survival in harsh environments. However, UreI is found in only a handful of *Helicobacters* while the divergence in periplasmic-associated lipoproteins is found throughout all ε proteobacteria. Though different from *E. coli* and *N. meningitidis*, those lipoprotein components found in *H. pylori* are highly conserved within ε proteobacteria, indicating the selective element is affecting the entire bacterial family, or at least an early common ancestor. Given the apparent absence of LolB and LolDE, lipoprotein transport in ε proteobacteria may be severely altered and the effect on lipoprotein transport may explain the divergence in lipoprotein components of both the Bam and Lpt transport pathways. Another possibility may be an alteration in membrane lipid composition in ε proteobacteria compared with other bacterial families. This explanation may explain the apparent inability to identify many of the lipoprotein components of all three membrane biogenesis transport systems, as potentially unique alterations in the lipid moiety of these components may be required for insertion into membranes of ε proteobacteria. The fact that the vast majority of sequence divergence in lipoprotein components of trafficking pathways in *H. pylori* were in domains not involved with interacting with the actual LPS, lipoproteins, or OM proteins indicates that the membrane lipid composition or lipoprotein localization may significantly differ in ε proteobacteria. Phospholipids are known to make up the majority of lipids in *H. pylori* (Hirai et al., [@B62]) and cholesterol glucosides, lipids rarely found in animals or bacteria, account for roughly 25% of the lipids in *H. pylori* (Haque et al., [@B59]; O\'Toole and Clyne, [@B103]), suggesting an altered membrane composition. As stated previously, inner and OMs in *Helicobacters* and *Campylobacters* are notoriously hard to separate, and the alterations seen in both lipid composition and the lipoproteins found in each of these three systems when compared with other bacterial families may offer clues as to the nature of this phenomena.

The field of membrane biogenesis in ε proteobacteria to date is remarkably unexplored. The recent studies undertaken by Chiu et al. have directly shown the importance of the LPS transport pathway components in membrane permeability and that a decrease in membrane integrity is achievable by removing the function of two of these components, resulting in an increased susceptibility of *H. pylori* to antibiotics (Chiu et al., [@B25], [@B26]). In addition, targeting these pathways not only has the potential to affect membrane permeability, but also prevent virulence determinants essential for the survival of *H. pylori* from being expressed on the bacterial surface. Despite having shown this correlation between OM biogenesis and membrane integrity, no studies to date have examined the effects of alterations in these pathways on pH resistance, adherence, or colonization in *H. pylori*. The argument could be made that, given the lack of an effective *H. pylori* vaccine and the emergence of antibiotic resistant organisms, the time has come to begin exploring therapeutics that target these three essential mechanisms by which all known colonization/virulence determinants are expressed on or secreted from the bacterial surface.
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